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Programmed cell death plays an important role in erythro-
poiesis under physiological and pathological conditions. In this
study, we show that the Notch/RBPjj signaling pathway
induces erythroid apoptosis in different hematopoietic tissues,
including yolk sac and bone marrow as well as in murine
erythroleukemia cells. In RBPjj/ yolk sacs, erythroid cells
have a decreased rate of cell death that results in increased
number of Ter119þ cells. A similar effect is observed when
Notch activity is abrogated by incubation with the c-secretase
inhibitors, DAPT or L685,458. We demonstrate that incubation
with Jagged1-expressing cells has a proapoptotic effect in
erythroid cells from adult bone marrow that is prevented by
blocking Notch activity. Finally, we show that the sole
expression of the activated Notch1 protein is sufficient to
induce apoptosis in hexametilene-bisacetamide-differentiating
murine erythroleukemia cells. Together these results demon-
strate that Notch regulates erythroid homeostasis by inducing
apoptosis.
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Introduction
Notch is a highly conserved signaling pathway that regulates
cell fate specification during development and adult tissue
homeostasis. Physiological activation of the Notch pathway
requires the interaction between the Notch receptor and one of
its ligands. This interaction leads to the cleavage of Notch
receptor, releasing the intracellular domain that translocates to
the nucleus to bind RBPjk and activate specific gene transcrip-
tion (reviewed by Bray1 and Lai2).
Notch function is required for the generation of definitive
hematopoiesis as shown by the lack of hematopoietic precursors
in the aorta of Notch1/ and RBPjk/ mouse embryos or in
mind bomb mutants in zebrafish.3–6 In contrast, primitive
hematopoiesis occurs in different Notch pathway mutants in
both mouse and zebrafish.3–5 In the mouse, primitive hemato-
poiesis originates in the blood islands of the yolk sac, starting at
embryonic day 7.5 (E7.5). The main component of this primitive
hematopoiesis is erythroid progenitor cells (EryP)7 that generate
large nucleated primitive erythrocytes that contain embryonic
globins (bH1, e-globin and z-globin) (reviewed by Palis and
Segel8).
Erythropoiesis involves the progressive differentiation of
uncommitted progenitors to mature erythrocytes. However,
not only differentiation but also apoptosis participates in the
regulation of cell survival and mature red cell turnover. The
amount of erythropoietin (Epo), mainly dependent on hypoxia,
is one of the key factors in controlling the survival of erythroid
cells (reviewed in Mulcahy9). Expression of the antiapoptotic
members of the Bcl-2 family, Bcl-2 and Bcl-x,10 are some of the
downstream effects of EpoR activation in this system. Consistent
with this, bcl-x/ embryos die of massive apoptosis in the
nervous system and in fetal liver erythroid cells.11
Other transcription factors including GATA1 and, more
recently, p53 have been implicated in regulating apoptosis at
different stages of erythroid maturation.12,13 In this sense,
GATA1 plays a key role in development and survival of
erythroid cells since GATA1-deficient cells failed to develop
beyond the proerythroblast stage and undergo rapid apoptosis.14
Notch pathway has previously been shown to induce
apoptosis in cell lines from different hematopoietic lineages
most likely through the activation of its target gene hes1.15–17
However, the overall data linking Notch and erythroid apoptosis
is controversial.18,19
In this work, we demonstrate that the Notch signaling
pathway is a positive regulator of apoptosis in primitive
erythropoiesis in the yolk sac but also in erythroid cells from
adult bone marrow (BM). Complementary studies using the




RBPjk/ mice have been described previously.20 Animals were
kept under pathogen-free conditions and experiments approved
by the Animal Care Committee. Yolk sacs were obtained from
timed pregnant females at days 7.5–9.5 of gestation and
dissected out from embryo and vitelline arteries. Embryos were
genotyped by polymerase chain reaction (PCR) and morpho-
logy. BM was obtained from 8 to 12-week wild-type (WT)
CD1 mice.
Cell lines and transfections
MEL cells21 were maintained in RPMI 10% fetal bovine serum
(FBS), 1% L-glutamine and 1% Pen/Strep. Stable clones of MEL
cells expressing N1DE22 or pcDNA.3 were obtained by
electroporation and expression was confirmed by western blot
(9E10 antibody). NIH-3T3 cells were transfected by calcium
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phosphate with Jagged1 construct23 and clones overexpressing
Jagged1 were selected in G418. Differentiation of MEL cells was
performed with 5 mM hexametilene-bisacetamide (HMBA;
Sigma, St Louis, MI, USA) for 6 days.
Dianisidine staining
O-dianisidine (Sigma) was used to stain hemoglobin of both
E9.5 WT and RBPjk-mutant yolk sacs, and MEL friend cells to
assay erythroid differentiation as described previously.21
Hematopoietic colony assay
Yolk sac from WT and RBPjk/ E7.5–9.5 embryos was digested
in 0.1% collagenase (Sigma) in phosphate-buffered saline
(PBS), 10% FBS for 30 min at 371C. Cells (30 000) were plated
in duplicates in 1% methylcellulose (Stem Cell Technologies,
Vancouver, Canada) plus Iscove’s with 10% FBS, 10% IL3-
and stem cell factor (SCF)-conditioned medium, 2.5% L-
glutamine, 0.1% monothioglycerol (Sigma), 1% Pen/Strep
(Biological Industries, Beit Haemek Kibbutz, Israel), 2 IU/ml
erythropoietin (Laboratorios Pensa-Esteve, Barcelona, Spain),
20 ng/ml granulocyte-macrophage colony-stimulating factor
(PeproTech, Rocky Hill, NJ, USA) and 100 ng/ml of granulocyte
colony-stimulating factor (Avantis Pharma, Paris, France).
After 7 days, the presence of hematopoietic colonies was
scored under a microscope. EryP colonies were scored
at day 3.
Flow cytometry analysis
Collagenase-disrupted yolk sac cells were stained with fluor-
escein isothiocyanate FITC-conjugated CD71, CD41, ckit,
CD45, and mac1 and PE-conjugated Ter119 and CD31
antibodies (Pharmingen, BD Biosciences, San Jose, CA, USA)
or isotopic immunoglobulin G as a control. Cells were analyzed
in a FACScalibur (Becton & Dickinson, BD Biosciences, San
Jose, CA, USA) and WinMDI 2.8 software. Dead cells were
excluded by 7-aminoactinomicin-D (7-AAD; Invitrogen, Carls-
bad, CA, USA) staining. For the AnnexinV binding analysis, cells
were stained with rh AnnexinV-FITC kit (Bender Medsystems,
Burlingame, CA, USA) and 7-AAD for 15 min according to the
manufacturer’s instructions.
For cell cycle analysis of total yolk sac, cells were fixed in
70% EtOH at –201C overnight, treated with 50mg DNAse-free
RNAse and stained with 25mg of propidium iodide (Sigma).
Ter119þ cell-cycle analysis was performed on fresh cells with
20mM Draq5 (Biostatus Ltd, Leicestershire, UK). FlowJo 6.4.1
software was used for cell-cycle analysis.
Yolk sac and BM cultures
Collagenase-disrupted yolk sacs were cultured for 6 days in
Iscove’s with 10% FBS, 10% IL3- and SCF-conditioned medium,
0.1% monothioglycerol in the presence of 50mM N-S-phenyl-
glycine-t-butylester (DAPT) (Invitrogen), 2mM L685,458 (Sigma)
or dimethyl sulfoxide (DMSO) as control. For BM culture,
1.5 105 whole BM cells were incubated with g-secretase
inhibitors in RPMI 10% FBS, 2 IU/ml EPO for 2–3 days. Z-Val-
Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK; Bachem, Buden-
dorf, Switzerland) was used at 200mM.
Coculture on 3T3 or 3T3-Jag1 stromal cells was perfomed
with 4 105 whole BM cells in RPMI, 10% FBS for 16 h. Cells
were assayed for AnnexinV binding and analyzed by flow
cytometry.
Immunohistochemisty
Yolk sacs were fixed with 4% paraformaldehyde (Sigma),
embedded in Paraplast (Sigma) and sectioned (10 mm). Slides
were dewaxed in xylene, antigen retrieval was performed by
boiling for 2 min in sodium acetate, rehydrated and blocked-
permeabilized in 10% FBS, 0.3% Surfact-Amps 100 (Pierce,
Aalst, Belgium) and 5% non-fat milk in PBS for 90 min at 41C.
Anti P-Ser10 H3 (Upstate, Charlottesville, VA, USA) was used at
1:500 dilution and developed with Dakocytomation kit (Dako,
Glostrup, DK, Denmark) following manufacturer’s instructions.
Hematoxilin (Merck, Whitehouse Station, NJ, USA) was used for
counterstaining.
For histological analysis, tissue samples were fixed overnight
at 41C in 4% paraformaldehyde, dehydrated and embedded in
Paraplast (Sigma). Samples were sectioned in a Leica-RM2135 at
4 mm and stained with hematoxilin and eosin.
Images were acquired with an Olympus BX-60 using a Spot
camera and Spot 3.2.4 software (Diagnostic Instruments,
Sterling Heights, MI, USA). Adobe Photoshop 6.0 software
was used for photograph editing.
Semiquantitative reverse transcriptase-polymerase
chain reaction
Total RNA from subdissected E9.5 WT and RBPjk/ yolk sacs
was isolated using TRIzol Reagent (Invitrogen). Poly-AT Tract
System IV (Promega, Madison, WI, USA) and RT-First Strand
cDNA Synthesis Kit (GE Healthcare, Buckinghamshire, UK)
were used to obtain mRNA and cDNA respectively. PCR
product was analyzed at different cycles to avoid saturation.
Quantity One software (Biorad, Hempstead, UK) was used for
densitometry. Primer pairs used in the experiments are listed in
Supplementary Table S1.
Quantitative RT-PCR
Ter119þ cells were sorted from E9.5 collagenase-treated
embryos in MoFlo cell sorter (Dakocytomation, BD Diagnostic,
San Jose, CA, USA). mRNA was isolated with Rneasy minikit
(Qiagen, Valencia, CA, USA) following manufacture’s instruc-
tions. qRT-PCRs were performed with SYBR Green I Master
(Roche, Basel, Switzerland) in LightCycler480 system.
Statistical analysis
Normal distribution of the samples was confirmed with one-
sample Kolmogorow–Smirnoff test and Student’s t-test was
performed.
Results
Absence of Notch signaling results in increased
number of erythroid cells in the yolk sac
Notch signaling has previously been shown to influence
differentiation and apoptosis of erythroid cells in vitro although
controversial observations have been reported.15,18,19,24 For
this reason, we aimed to characterize the physiological role of
the Notch pathway in erythropoiesis by comparing WT and
RBPjk/ embryos. Despite the absence of intraembryonic
hematopoiesis in the RBPjk/ embryos and the presence of
different angiogenic abnormalities in the yolk sac, we found that
primitive hematopoiesis does occur in the yolk sac of the
RBPjk/ embryos (Figure 1a), similar to the Notch1/
mutants.25–27
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Figure 1 Increased number of erythroid cells in RBPjk/ yolk sacs. (a) Images of E9.5 WT and RBPjk/ embryos with the yolk sac (upper panel)
and hematoxilin/eosin staining of yolk sac sections. Total number of cells obtained from disrupted yolk sacs (right panel). (b) Semiquantitative RT-
PCR of Notch receptors, ligands and target genes from E9.5 WT and RBPjk/ yolk sacs. (c) Representative analysis of Ter119þ cells from E7.5
and E9.5 WT and RBPjk/ yolk sacs. (d) Percentage of Ter119þ cells in the analyzed E9.5 WT and RBPjk/ yolk sacs. Average and s.d. are
represented.
Figure 2 Proliferation in E9.5 WT and RBPjk/ yolk sac cells. (a) Graphs represent the total number of CFC types obtained from WT or RBPjk/
yolk sacs. (b) Representative cell-cycle analysis from total and Ter119þ cells from E9.5WT or RBPjk/ yolk sacs. Average values and s.d. from
two yolk sacs are shown. (c) IHC of P-Histone3 in yolk sac sections. Numbers represent the average percentage of positive cells inside the blood
islands found in four independent stainings. Arrowheads indicate cells with positive staining; e, endothelium; en, endoderm; bc, blood cells.
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To determine whether Notch pathway plays a role in
regulating hematopoiesis in the yolk sac, we first analyzed the
expression of different Notch receptors, ligands and Notch-
target genes in the yolk sac of WT and RBPjk/ embryos by
semiquantitative RT-PCR and we observed that all Notch family
genes are expressed in the yolk sac at E9.5 (Figure 1b). In
RBPjk/, we found reduced expression of all ligands and
receptors, whereas Notch3 and Jagged2 were upregulated. We
also tested the expression of Notch-target genes and detected a
consistent reduction in hes1 levels in RBPjk/ yolk sacs
compared with WT (Figure 1b).
Since hematopoiesis in the yolk sac is mainly restricted
to erythropoiesis, we determined the percentage of cells
expressing the erythroid marker Ter119 in collagenase-treated
yolk sacs at E7.5, E8.5 and E9.5. We detected a few positive
cells in the yolk sac of E7.5 (Figure 1c) and E8.5 (data not
shown). At day 9.5, the percentage of Ter119þ in the yolk sac
ranged from 20 to 40% in the WT and 40–60% in the RBPjk/
(Figure 1c and d) being similar the total number of cells per yolk
sac (Figure 1a).
Proliferation is not responsible for increased
erythropoiesis in RBPjk/ yolk sacs
To investigate whether the higher number of Ter119þ cells in
the RBPjk/ yolk sac was owing to an increase in the number of
progenitors, we performed colony-forming cell (CFC) assays
with collagenase-treated yolk sac cells at E7.5, E8.5 and E9.5
from RBPjkþ /þ ,þ / and / embryos. We detected a similar
percentage of myeloid, erythroid and mixed colonies in these
cultures (Supplementary Figure S1), however; at E9.5, there was
a twofold increase in the total number of CFC in mutant
embryos (Figure 2a). To test whether this effect was due to
increased proliferation, we analyzed the cell-cycle profile of WT
and RBPjk/ yolk sac cells by flow cytometry. Surprisingly, the
percentage of cells in S/G2–M phase was slightly reduced in
RBPjk/ compared with WT cells (from 53 to 45%), and this
reduction in S/G2–M phase was higher when cell cycle was
analyzed in the Ter119þ cells (Figure 2b). To confirm this
observation, we performed the P-H3 staining on yolk sac
sections to assess the number of cells undergoing mitosis inside
the blood islands. P-H3 staining showed that hematopoietic
Figure 3 Erythroid differentiation is not impaired in RBPjk/ yolk sacs at E9.5. (a) Representative dot plots showing expression of CD45
(hematopoietic marker) versus CD31 (endothelial marker) and mac1 (macrophage marker). (b) Representation of erythroid differentiation markers
(upper). Dot plots of representative erythroid subpopulations from three WT and RBPjk/ yolk sacs. Dianisidine staining of circulating cells from
the yolk sac (lower panels). Numbers represent the average and s.d. of positive cells counted in three different samples. (c and d) qRT-PCR of (c)
globin genes and hemo maturation enzime genes and (d) erythroid-specific transcription factors from WT and RBPjk/ yolk sacs.
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cells from the WT yolk sacs have a similar mitotic rate (19.8 %)
than cells in RBPjk/ yolk sacs (12.9 %); (Figure 2c). Altogether
these results indicate that proliferation is not increased in the
RBPjk/ yolk sac erythroid cells.
Normal differentiation occurs in RBPjk/ yolk sac
Although hematopoiesis is mainly restricted to erythropoiesis in
the yolk sac, different progenitor types and macrophages are
also generated. As we detected increased number of different
hematopoietic progenitors in the RBPjk/ (Figure 2a), we
speculated that the decision between hematopoietic and
endothelial lineages may be affected. To test this possibility,
we analyzed the expression of CD45 (hematopoietic excluding
erythroid cells) and CD31 (endothelial) cell markers. We
detected a similar number of cells expressing these markers,
indicating that the non-erythroid hematopoiesis is normally
occurring in the RBPjk/ yolk sac (Figure 3a). Consistent with
this observation, we did not detect any difference in the
percentage of endothelial cells (CD31þ and CD45; Figure 3a)
or in the expression of PECAM or VE-cadh genes in these yolk
sacs (Supplementary Figure S4), in contrast to that previously
observed in the intraembryonic endothelial/hematopoietic
differentiation3,6 In addition, no major differences were found
in the percentage of mac1þ cells between WT and RBPjk/
(Figure 3a).
We next investigated whether the higher number of Ter119þ
cells in the RBPjk/ was due to a blockage in erythroid
differentiation. Thus, we characterized the different erythroid
subpopulations by analyzing the expression of specific differ-
entiation markers CD71, CD41 and c-kit in the Ter119þ
population by flow cytometry. As shown in Supplementary
Figure S2, CD71 was expressed in all Ter119þ cells in both WT
and RBPjk/ yolk sacs, this result is surprising since this marker
is downregulated during erythroid differentiation in BM.28
Analysis of other differentiation markers showed that the
different Ter119þ subpopulations were similarly represented
in WT and mutant yolk sacs (Figure 3b). We also analyzed the
expression of erythroid transcription factors and globin genes in
purified Ter119þ cells from WT and RBPjk/ embryos by qRT-
PCR. We did not detect major differences in the expression of
the embryonic globins and hemo group maturation enzymes
(ALAD and ALAS2; Figure 3c) or in the percentage of circulating
yolk sac cells showing dianisidine staining (from 85% to 72%;
Figure 3b); however, a threefold increase in the expression of
adult b-globin was observed in the RBPjk/ cells compared
with the WT (Figure 3c). We also detected overexpression of the
erythroid transcription factor NFE2 in RBPjk/ erythroid cells,
whereas no significant differences were detected in GATA1,
KLF2 and EKLF levels (Figure 3d). Surprisingly, we did not
observed downregulation of the hes1 gene in the Ter119þ cells
of the RBPjk/ embryos (data not shown).
Reduction of apoptosis in Notch-defective yolk sac
erythroid cells
Apoptosis is a crucial mechanism for maintaining the home-
ostasis of the erythroid lineage. Since minor differences in
Figure 4 RBPjk/ and g-secretase inhibitor-treated erythroid cells show reduced apoptosis. (a) Dot plot of AnnexinV and 7-AAD staining in a
representative E9.5 WT and RBPjk/ yolk sac. (b) Percentage of AnnexinVþ 7AAD– cells in the Ter119þ cells in E9.5 WT and RBPjk/ yolk
sacs. (c) Relative expression of pro- and antiapoptotic genes in E9.5 RBPjk/ compared with WT yolk sacs by qRT-PCR. (d and e) Graphs represent
the percentage of Ter119þ cells (d) and AnnexinVþ7AAD-cells (e) from E9.5 WT yolk sacs after 5 days of culture in DMSO, 50mM DAPT or 2mM
L685,458. (f) Dot plots from a representative experiment.
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proliferation or differentiation were found in the RBPjk/
mutants, we tested whether the increased number of erythroid
cells in these embryos was due to differences in apoptosis. We
detected a significant reduction (Po0.05) in the apoptotic
rate as measured by AnnexinV binding in the RBPjk/ yolk
sacs that was specific for the erythroid Ter119þ population
(Figure 4a and b).
Next, we analyzed the expression levels of different genes that
are associated with apoptosis in purified Ter119þ cells. By
qRT-PCR, we detected 3–4-fold increase in the expression levels
of the erythroid survival factor EPO, its receptor and its
downstream effectors, the antiapoptotic bcl-2 and bcl-x genes
in the RBPjk/ cells compared with the WT. This suggests that
EpoR-mediated signaling may be participating in the increased
survival of RBPjk/ Ter119þ cells. In contrast, no major
differences were found in the expression levels of p53 family
genes although one of its proapoptotic targets puma was
increased in the mutant cells compared with the WT
(Figure 4c, right panel).
To further demonstrate that reduced apoptosis in the RBPjk/
erythroid cells was dependent on Notch function, we obtained
WT cells from disrupted yolk sacs and incubated in liquid
culture in the presence or absence of the g-secretase inhibitors
DAPT and L685,458. After 6 days of culture, both the total
number and the percentage of TER119þ cells was significantly
increased in the DAPT-treated cells compared with the control
(Figure 4d) resembling the RBPjk/ phenotype. The increase in
the Ter119þ population correlated with a threefold reduction
in the percentage of AnnexinVþ cells in the DAPT- and
L685,458-treated cells (Figure 4e and f). In agreement with the
differences in gene expression found in the RBPjk/ yolks sacs,
upregulation of EPO, its receptor, bcl-2 and bcl-x was detected
in the g-secretase-treated Ter119þ cells (Supplementary Figure
S5). Together these results indicate that Notch activity regulates
apoptosis in the erythroid lineage in the yolk sac.
Notch activation induces apoptosis in adult BM
erythroid and MEL cells
We next investigated whether Notch activation was regulating
apoptosis not only in the yolk sac but also in adult erythro-
poiesis. Since RBPjk/ mutants do not generate definitive
hematopoiesis and die at E10.5, we isolated BM from WT adult
mice and performed cell cultures in the presence of DMSO,
DAPT or L685,458. We observed a 30% decrease in the
percentage of AnnexinVþ cells in the Ter119þ population
after 2 days of culture in g-secretase inhibitors compared with
the control (Figure 5a). Interestingly, Ter119-negative cells were
not protected from apoptosis by DAPT in these cultures (data not
shown), indicating the specific proapoptotic effect of Notch
activity on the erythroid lineage. Conversely, incubation of total
BM cells from adult mouse on NIH-3T3-Jag1 cells resulted in a
Figure 5 Notch activity induces apoptosis in the Ter119þ cells from adult bone marrow and murine erythroleukemia cells. (a) Graphs represent
the percentage of AnnexinVþ7AAD- in the Ter119þ population of BM cultured in the presence of DMSO, DAPT or L685,458. Average
percentage and s.d. of three different experiments are shown. (b and c) Representative flow cytometry analysis of AnnexinV binding in the
Ter119þ cells from BM incubated on 3T3 or 3T3-Jag1 for 16 h (b). Graphs represent the average and s.d. of 3T3-Jag1-induced apoptosis observed
in three different experiments incubated with DAPT and L685,458 as measured by AnnexinVþ7AAD- in Ter119þ cells (c). (d) Graphs represent
the average percentage of AnnexinVþ 7AAD- cells in Notch1DE expressing MEL clones (F1, F4) compared with control clones (D3, F3) in
proliferantion media (black bars) or after 6 days of differentiation in 5 mM HMBA (gray bars). Western blot shows the expression of Notch1DE.
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2–3-fold increase in the percentage of AnnexinVþ Ter119þ
population compared with that incubated on NIH-3T3 control
cells (P¼ 0.04) (Figure 5b and c). Moreover, this effect was
prevented in the presence of g-secretase inhibitors DAPT
(P¼ 0.01) or L685,458 (P¼ 0.002; Figure 5c) and the caspase
inhibitor Z-VAD-FMK (data not shown).
To further demonstrate that Notch was sufficient to induce
apoptosis in erythroid cells, we generated different clones of
MEL cells expressing the active Notch1 fragment, N1DE. Cells
expressing N1DE differentiated and proliferated similar to the
controls (Supplementary Figure S3); however, these cells
showed a higher percentage of AnnexinV binding after 6 days
in culture under differentiating conditions (HMBA) as expected
(Figure 5d).
Altogether our results indicate that Notch positively regulates
apoptosis in embryonic and adult erythropoiesis and in
differentiating erythroleukemia cells.
Discussion
Notch signaling had been linked previously to regulate
apoptosis in erythroid cells, although it was unclear whether
Notch inhibits or promotes apoptosis. We have now used
primary cells from yolk sac and BM to elucidate the
physiological effect of Notch activation on the erythroid lineage.
We demonstrate that the Notch pathway is a positive inducer of
apoptosis in erythroid cells from different tissues.
Although different cytokines regulate the integrity of the
erythroid compartment, production of definitive erythroid cells
is mainly dependent on Epo.29 Signaling from EpoR through
Jak2/Stat530,31 prevents apoptosis on this cell lineage from late
erythroid progenitors (CFU-E) until the onset of hemoglobiniza-
tion,32,33 and one important target gene of this cascade is
bcl-x.34 Studies using bcl-x-null mice demonstrated a critical
role for this gene at the end of erythroid maturation when
maximal hemoglobin synthesis occurs.35 RBPjk/ erythroid
cells show a clear upregulation of genes involved in this
antiapoptotic pathway, such as EPO, EPO-R, bcl-x and bcl-2,
suggesting that Notch may induce apoptosis by impinging on
this pathway. Previous reports have attempted to link Notch
induction of apoptosis through the p53 pathway in other
systems.36,37 We have also explored that possibility in erythroid
cells, since there is increasing evidence of p53-mediated
apoptosis at different stages of erythroid differentiation;13,38
however, our results show that crucial p53 pathway genes are
not affected in the RBPjk/ erythroid cells suggesting that this
pathway is not responsible for the protection of apoptosis in the
RBPjk mutants. In fact, we found an erythroid-specific
upregulation of the proapoptotic p53-target gene, puma, in the
RBPjk/ Ter119þ cells, which is surprising since this
population has a lower apoptotic rate.
Although previous reports have attempted to decipher which
is the Notch function in apoptosis of erythroid cells,15,19 this is
the first time that this question is addressed in primary cells. The
use of cell lines in the previous published reports may explain
the controversial data. Our data is in agreement with the results
from Ishiko et al.15 using K562 cells in which Notch activity
induces apoptosis. In this system, Notch activation led to
downregulation of bcl-x, likely through repression of GATA1 by
hes1 under differentiation conditions.15 Similarly, we found
increased levels of bcl-x and bcl-2 in the Ter119þ cell
population of RBPjk/; however, we did not detect any change
in hes1 and GATA1 levels in this model. The observation that
hes1 is not affected by the lack of RBPjk in particular cell types
has already been described and explained by the repressor
function of RBPjk in the absence of Notch signaling (reviewed
by Lai2).
We now have used different approaches including the Notch
loss-of-function RBPjk/ embryos, g-secretase inhibitors and
Jag1-expressing cell co-culture to investigate the role of Notch
signaling in regulating apoptosis on erythroid cells. Together,
our results confirm that Notch activation favors apoptosis in this
particular lineage and this finding may be particularly relevant
in some erythroid disorders. In fact, erythropoiesis in the
RBPjk/ embryos resembles the one observed in myelodys-
plastic syndrome (MDS)-derived leukemias or polycytemia vera.
These human myeloproliferative syndromes cause the over-
production of erythroid cells, mainly because of activating
mutations in the Jak2 kinase and this leads not only to increased
cell proliferation but also upregulation of bcl-x (reviewed by
Campbell and Green39) and protection from apoptosis. In this
scenario and based on our results, it is particularly interesting to
investigate whether the Notch pathway is deregulated in these
tumors. In this sense, higher expression of the Notch-like ligand,
dlk, in MDS compared with myeloid leukemia cells has been
detected by microarray analysis.40
Notch activation has previously been associated to inhibition
of apoptosis in normal endothelial41 and T cells,42 likewise in
neoplastic cells including Kaposi’s sarcoma,43 glioma44 and
Hodgkin’s lymphoma45 cells. Conversely, Notch activation can
induce apoptosis during the development of the retina46 and the
serotonin lineage47 in Drosophila. Notch also induces apoptosis
in B-cell lymphomas,16 normal monocytes48 or hepatocellular
carcinoma cells.49 Based on this and our results, it is likely that
apoptosis is another mechanism used by Notch to control
specific tissue homeostasis.
Altogether, our results indicate that the activation of the
Notch pathway is able to regulate the erythroid lineage in
different hematopoietic tissues by inducing apoptosis.
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